Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Current guidelines on stress ulcer prophylaxis

M Tryba1, D Cook

  • 1Department of Anaesthesiology, Intensive Care Medicine and Pain Therapy, University Hospital Bergmannsheil, Bochum, Germany. tryba@gus.de

Drugs
|October 27, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prevalence and predictors of posttraumatic stress disorder in Stevens Johnson syndrome and toxic epidermal necrolysis.

Journal of the European Academy of Dermatology and Venereology : JEADV·2025
Same author

Uterine cancer restaging according to the updated 2023 FIGO Guidelines does not uniformly affect prognosis: An institutional retrospective cohort study.

Gynecologic oncology·2024
Same author

Achievement of Target Gain Larger than Unity in an Inertial Fusion Experiment.

Physical review letters·2024
Same author

Determination of Residual Control and Concentration of Chlorantraniliprole in Soybean.

Journal of economic entomology·2023
Same author

Lawson Criterion for Ignition Exceeded in an Inertial Fusion Experiment.

Physical review letters·2022
Same author

Influence of Soil Moisture Zones on Rice Water Weevil (Coleoptera: Curculionidae) Populations in Furrow Irrigated Rice.

Environmental entomology·2021
Same journal

Botulinum Toxin Type A for Trigeminal and Postherpetic Neuralgia: An Umbrella Review of Systematic Reviews.

Drugs·2026
Same journal

Biologics and Small Molecule Inhibitors: Novel Therapeutic Strategies for Cutaneous Adverse Drug Reactions.

Drugs·2026
Same journal

Use of Sedative-Hypnotic Drugs and the Risk of Developing Alzheimer's Disease: A Systematic Review, Meta-Analysis and Meta-Regression.

Drugs·2026
Same journal

Relacorilant: First Approval.

Drugs·2026
Same journal

Developmental Progress and Future Potential for Inhaled Biologics in the Treatment of Respiratory Diseases.

Drugs·2026
Same journal

Linerixibat: First Approval.

Drugs·2026
See all related articles

Preventing upper gastrointestinal bleeding in intensive care units (ICUs) involves managing gastric acidity and improving microcirculation. Sucralfate is the most cost-effective option for at-risk patients.

Area of Science:

  • Critical Care Medicine
  • Gastroenterology
  • Pharmacology

Background:

  • Acute upper gastrointestinal bleeding in ICU patients stems from various causes like peptic ulcers, drug effects, and stress-induced lesions.
  • Gastric mucosal ischemia from hypotension and shock is a primary risk factor for stress ulcer bleeding.
  • Gastric acid hypersecretion is common in patients with head trauma or neurosurgical procedures.

Purpose of the Study:

  • To review the causes, risk factors, and preventive strategies for acute upper gastrointestinal bleeding in intensive care unit (ICU) patients.
  • To evaluate the efficacy and cost-effectiveness of various prophylactic agents.
  • To provide guidance on appropriate stress ulcer prophylaxis selection.

Main Methods:

  • Review of existing literature on stress ulcer prophylaxis in ICU settings.

Related Experiment Videos

  • Analysis of European-approved drugs for stress ulcer prophylaxis, including H2 antagonists, antacids, pirenzepine, and sucralfate.
  • Comparison of drug efficacy, adverse effects, and cost-effectiveness.

    • Main Results:

    • All approved European drugs (H2 antagonists, antacids, pirenzepine, sucralfate) demonstrate efficacy in randomized trials.
    • Optimized resuscitation and ICU management to improve oxygenation and microcirculation are crucial prophylactic measures.
    • Sucralfate emerges as the most cost-effective prophylactic agent.
    • Prostaglandins and omeprazole are not recommended due to insufficient data.
    • Stress ulcer prophylaxis is indicated only for high-risk ICU patients.

    Conclusions:

    • Stress ulcer prophylaxis requires careful patient selection based on risk factors.
    • Drug choice should balance efficacy, safety, and cost, with sucralfate being the most economical.
    • Improved ICU management has reduced the incidence of nosocomial pneumonia linked to gastric bacterial overgrowth.